The national hepatitis strategies, Viral Hepatitis Mapping Project reports, and more…
| Click on the images to access, or view all resources added in the last month |
Sixth national hepatitis C strategy 2025 – 2030
Canberra, Australian Government Department of Health and Aged Care, 2026.
The vision statement for this strategy is that by 2030, hepatitis C will be eliminated as a public health threat in Australia. Everyone will have equitable access to safe, affordable, and effective prevention, harm reduction, education, testing, and treatment including appropriate person-centred care and support. People impacted by hepatitis C are active decision makers in their care, live free from stigma, discrimination, and racism and lead healthy and productive lives.
Fourth national hepatitis B strategy 2025 – 2030
Canberra, Australian Government Department of Health and Aged Care, 2026.
The vision statement for this strategy is that by 2030, hepatitis B will be eliminated as a public health threat in Australia. Everyone will have equitable access to safe, affordable, and effective prevention, harm reduction, education, testing, and treatment including appropriate person-centred care and support. People impacted by hepatitis B are active decision makers in their care, live free from stigma, discrimination, and racism and lead healthy and productive lives.
Viral Hepatitis Mapping Project: Hepatitis C National Report 2024–2025
Sydney, ASHM, 2025.
Further assessment of trends in treatment for hepatitis C through May 2025. First-ever national reporting of hepatitis C treatment numbers and trends among Aboriginal and/or Torres Strait Islander people. Updated assessment of prescribing trends according to provider, including GPs and NPs.
Viral Hepatitis Mapping Project: Hepatitis B National Report 2024
Sydney, ASHM, 2026.
Includes data regarding hepatitis B, as well as estimates of viral hepatitis testing and liver cancer. The most recent available estimates for prevalence, treatment and care of hepatitis B to the end of 2024.
Hepatitis D
Canberra, Hepatitis Australia, 2026.
Hub for information on hepatitis D, developed in collaboration with hepatitis community organisations, infectious disease experts, and people with lived experience of hepatitis B and hepatitis D.
Prisons worldwide failing to provide adequate health care for blood-borne disease
Sydney, Medical Journal of Australia, 2026.
Globally, one-in-nine incarcerated people have a history of IV drug use. In Australia and New Zealand, it’s one-in-two. The University of New South Wales (UNSW) has become the first to quantify, in two systematic reviews, both the prevalence of blood-borne diseases for incarcerated people, and access to a handful of well-known healthcare programs. It found that no country, worldwide, had all the programs available.
| To view the full list of newly added titles visit our library home page |
Posted 29 May 2026
More from:
Enjoyed this article? Subscribe to be notified whenever we publish new stories.
Subscribe for Updates
